Tag: opioids

  • Pawn Stars: The Opioid Edition

    Pawn Stars: The Opioid Edition

    If you are at risk for overdose or use needles to shoot up drugs, come see Brandi and she’ll take care of you – no frills, no questions, no judgment.

    On a cold November morning in 2015, Brandi Tanner and her husband stopped to pick up their 10-year-old niece from her grandmother’s house.

    “Grandma’s sleeping funny,” said the little girl when they came to the door. She wasn’t dressed for school, as she usually would be at this time of morning. Concerned, Tanner and her husband stepped into the house and headed for his mother’s bedroom. They knocked on the door, but no one answered. Glancing at each other with wide eyes, they swung open the door. Grandma had rolled off the bed and her body was wedged between the dresser and the nightstand. She wasn’t breathing.

    “I didn’t really have time to process that she was dead,” says Tanner. “The only thing I could think was ‘Damn, I need to call people. I need get the family out of the house so the police can take pictures.’”

    Tanner’s mother-in-law had died of an opioid overdose, an increasingly common cause of death in Vance County, North Carolina. Tanner herself had previously struggled with dependence on opioids and though the years she’d seen the prevalence of addiction rise in her community.

    “It was so hard to see my husband lose his mother,” she says. “I wanted to do something to help him and other people, but I didn’t know what to do.”

    About a month after her mother-in-law’s death, Tanner was working at a pawn shop where she had been employed for several years. It was right before closing and she was tired. Every day people came into the shop to sell items in order to buy opioids. And it seemed like every week she received news of someone else who had lost a family member. She had just started to shut down the register when a tall stranger strode into the shop.

    “There were other employees in the store but he headed straight for me like he knew I was the one who needed him,” Tanner recalls. “He walked up and asked if I wanted to help save lives from overdose. I was like, hell yeah. Where do I sign up?”

    The tall stranger was Loftin Wilson, an outreach worker with the North Carolina Harm Reduction Coalition, a statewide nonprofit that works to reduce death and disease among people impacted by drugs. That year, the organization had received a federal grant to prevent overdose death in Vance County in partnership with the Granville-Vance District Health Department. Over the past few years, the two agencies have worked closely to increase access to harm reduction services and medication-assisted treatment in Vance County.

    Vance is a rural community of fewer than 50,000 people. Driving through, one can’t help but notice large, pillared villas adjacent to dilapidated trailer parks, a scene that amidst acres of yellowing tobacco fields is reminiscent of plantations and slave quarters. In Vance County, a quarter of the population lives below the poverty line and addiction has flourished. From 2008-2013 Vance had the highest rate of heroin overdose deaths in the state: 4.9 residents per 100,000 compared to the state average of 1.0 per 100,000 (NC Injury Violence Prevention Surveillance Data). But those were sunnier days. By 2016, the heroin overdose rate for Vance County had jumped to 11.2 per 100,000. In 2017, based on provisional data, it was 24.2 per 100,000 (NC Office of Medical Examiners) and 2018 is already shaping up to be the deadliest year yet.

    The chance meeting between Wilson and Tanner at the pawn shop proved to be pivotal to outreach efforts in Vance County. Wilson had years of overdose prevention experience in a neighboring county, Durham, but Tanner knew her community and everyone in it. The two teamed up and began reaching out to people in need. Driving around in Wilson’s rattling pick-up, they visited the homes of people at risk for opioid overdose to distribute naloxone kits.

    The following summer, the North Carolina General Assembly legalized syringe exchange programs, and Wilson and Tanner began delivering sterile injection supplies along with naloxone. By 2018, a grant from the Aetna Foundation to combat opioid overdose had enabled them to purchase a van in which to transport supplies and to expand outreach work in Vance County.

    In July 2018 I visited Tanner at the pawn shop, where she still works. Thanks to Tanner’s efforts, the pawn shop has become a de facto site for syringe exchange and overdose prevention. Walking into the shop, the first thing I notice is that Tanner packs a glock on her right hip. It’s necessary these days in Vance County, which has seen a remarkable rise in drug-related gang violence this year. In March 2018, nine people were shot over a span of two weeks in Henderson, a small town of 15,000 residents. In May, four more people were killed in less than a week, prompting Henderson Mayor Eddie Ellington to make a formal plea to the state for resources. One of the murders occurred at a hotel a stone’s throw from the pawn shop.

    The danger doesn’t seem to faze Tanner. She weaves through displays of jewelry, rifles, and old DVDs as customers drop in to buy and sell. It’s a respectable stream of business for a Monday afternoon. Tanner handles the customers with ease, teasing them in a thick southern twang, inquiring after their kids and families, and discussing the murders, which more than one person brings up unprompted. She calls everyone “baby” and is the kind of person who will buy gift cards and toiletries just so she can slip them unnoticed into a customer’s bag if she knows the individual is down on her luck.

    Later in the afternoon, a young female enters the shop. She and Tanner nod at each other without exchanging words. Tanner finishes up a transaction with a customer and slips out the back door. She is gone for a couple of minutes, then reappears alone. This, I come to find, is what overdose prevention looks like in Vance County.

    “I used to hand out [overdose prevention supplies] from inside the shop, but people were embarrassed to come in and be seen taking them,” explains Tanner. “Now people just text me to let me know they are coming. Sometimes they come in the shop and other times I just leave my truck open out back and they get the supplies and leave.”

    Henderson is the kind of town where everyone knows everyone’s business. News travels fast and so do rumors. Even though almost everyone has someone in their family using opioids, stigma still runs deep, so Tanner doesn’t advertise the exchange. Word travels by mouth: If you are at risk for overdose or use needles to shoot up drugs, come see Brandi and she’ll take care of you – no frills, no questions, no judgment. She sees a couple participants a day on weekdays and nearly a dozen every Friday and Saturday. A couple times a week she drives her truck to visit people who don’t have transportation, just to make sure they are taken care of too.

    I ask Tanner to take me to her truck where she keeps the supplies, and she obliges, leading me behind the store to a dusty parking lot where her SUV is stuffed with naloxone, syringes, and other sterile injection equipment. I pepper her with questions as she moves the boxes around to show me what’s inside.

    Tanner looks younger than her 35 years, but acts much older. Over the next half hour she recounts a life of homelessness, addiction, incarceration, losing friend after friend to opioid overdose, and finding her mother-in-law’s body three years ago. She relates the stories as though we were discussing the weather, completely emotionless, but still, you can tell it hurts.

    “I try not to think about it,” she says with a wave of her hand when asked how she handles the trauma of losing so many people. Later, she admits that some nights she sits at home and writes down her feelings, then tears up the thoughts and throws them away.

    “It’s hard not to get attached to people if you see them every week,” she acknowledges. “But I do the work because I want to help my town and my people. This is the place where my kids are growing up.”

    We go back inside and I take a last look around the store. The blue-screened computers and racks of DVDs create the feeling that you’ve gone back in time, yet in some ways this pawn shop is the most forward-thinking entity in Vance County. Here, people received tools to save lives even before they were legal.

    Before leaving Vance’s open fields to return to the city, I ask Tanner if she has a final message for people at risk for opioid overdose. For a moment, her voice hardens.

    “I know what it feels like to not have anybody give a shit if you are here or not,” she says. Then her tone softens. “But I want people to know they are not alone. There are people out there who care and can help.”

    View the original article at thefix.com

  • Are Opioid Prescription Regulations Actually Working?

    Are Opioid Prescription Regulations Actually Working?

    New studies explored whether medical professionals are adhering to stricter opioid prescribing rules and regulations.

    While rules and regulations are often made in the interest of public safety, that doesn’t mean they are always followed hard and fast. 

    Such is the case with certain rules regarding opioid prescriptions, according to the Boston Globe. The paper states that according to the results of two studies published Wednesday (August 22) in the journal JAMA Surgery, “such well-intentioned efforts sometimes don’t have the desired effect.”

    The first study concluded that after one rule made it more difficult to refill the painkiller hydrocodone, surgeons began prescribing more of the medication right after surgery instead. 

    Meanwhile, the second study examined a regulation which required surgeons to check a database before prescribing opioids, the idea being that the database would alert them to patients at risk of opioid misuse.

    However, the study found that the procedure took up surgeons’ time but did not affect their prescribing practices in one New Hampshire hospital. 

    According to the Globe, both the studies were limited in terms of geographic area and only studying surgeon’s prescribing behaviors.

    Dr. Michael Barnett, a Harvard health-services researcher who studies opioid prescribing, tells the Globe that the results point to a bigger problem.

    “Clinician behavior is harder to predict, when you put these kinds of limits on it, than we’d like to think,” he said. “Regardless of the law you put in place, physicians are going to respond to what patients need… We need to ask a harder question: How do we influence health care decisions?”

    Prescribing practices have been under scrutiny for a number of years. In 2014, the Globe states, the U.S. Drug Enforcement Administration (DEA) changed hydrocodone from a Schedule III to a Schedule II drug, meaning patients would not be able to refill it over the phone.

    After that went into effect, researchers at the University of Michigan chose to study the effects on post-surgery prescribing. They looked at prescriptions for 21,955 patients who had had elective surgery in 75 Michigan hospitals from 2012 to 2015. Study authors found that prescription refills decreased, but the number of pills a patient left the hospital with increased.

    According to study author Dr. Michael Englesbe, the idea seemed to be that if doctors gave patients more prescriptions, they would be more likely to have the necessary pain relief and not seek more medication.

    However, Englesbe says, previous research indicates that “the number of pills you give someone has no relationship to their likelihood of calling for a refill. The more pills you give a patient, the more they take, and they don’t rate their pain care any better. It’s counterintuitive.”

    View the original article at thefix.com

  • Trump To Jeff Sessions: Sue Drug Companies For Opioid Crisis Role

    Trump To Jeff Sessions: Sue Drug Companies For Opioid Crisis Role

    The Attorney General said he would take action on Trump’s requests. 

    President Donald Trump has instructed Attorney General Jeff Sessions to file a federal lawsuit against pharmaceutical companies in Mexico and China, claiming that they have played a role in the US opioid epidemic.

    Last week, according to the New York Post, the president threw blame at China and Mexico for their roles in the opioid epidemic, claiming the countries had manufactured some of the illegal opioids coming into the United States.

    “In China, you have some pretty big companies sending that garbage and killing our people. It’s almost like a form of warfare. I’d like you to do what you can legally,” Trump said to Sessions.

    Fox News reports that Trump’s remarks came during a Cabinet meeting on Thursday, Aug. 16. Fox notes it was somewhat unusual that Trump asked for a new “major” lawsuit to be filed, rather than asking Sessions to join existing lawsuits filed by various US states. 

    “I’d also like to ask you to bring a major lawsuit against the drug companies on opioids,” Trump stated at the meeting, according to Fox. “Some states have done it, but I’d like a lawsuit to be brought against these companies that are really sending opioids at a level that — it really shouldn’t be happening. … People go into a hospital with a broken arm, they come out, they’re a drug addict.”

    Sessions said he would take action on Trump’s requests. 

    “We absolutely will,” Sessions said at the meeting. “We are returning indictments now against distributors from China; we’ve identified certain companies that are moving drugs from China, fentanyl in particular. We have confronted China about it … Most of it is going to Mexico and then crossing the border, unlawfully, from Mexico.”

    As of now, more than 25 US states have filed more than 1,000 lawsuits against opioid distributors and manufacturers.

    Last week, New York filed a lawsuit against Purdue Pharma, stating the manufacturer of the painkiller OxyContin has mislead medical professionals and patients about the dangers of the medication. Massachusetts also filed a lawsuit against the company in June, accusing the company of a “web of illegal deceit.” 

    According to recent estimates, overall overdose deaths in the US in 2017 were about 72,000 — an increase of 6,000 from 2016’s estimates.

    However, preliminary 2018 data implies that the “numbers may be trending downward in the wake of the Trump administration’s efforts to curb the epidemic.”

    View the original article at thefix.com

  • DEA Wants More Medical Marijuana, Fewer Opioids To Be Produced In 2019

    DEA Wants More Medical Marijuana, Fewer Opioids To Be Produced In 2019

    The new quotas are in line with the federal government’s goal of cutting opioid prescriptions by one-third in three years.

    When setting quotas for marijuana and opioid production for 2019, the Drug Enforcement Administration (DEA) did the unexpected.

    The DEA is raising the quota of cannabis that can be grown in the United States from 1,000 pounds (in 2018) to 5,400 pounds for 2019, Forbes reported.

    And in an attempt to push back on the opioid crisis, the agency lowered the production quota of opioids including oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine and fentanyl.

    The quotas represent “the total amount of controlled substances necessary to meet the country’s medical, scientific, research, industrial, and export needs for the year and for the establishment and maintenance of reserve stocks,” the DEA said in a press release.

    The opioid quota reductions are in line with the federal government’s goal of cutting opioid prescriptions by one-third in three years.

    According to U.S. Attorney General Jeff Sessions, there’s already been “significant progress” in doing so in the last year.

    “Cutting opioid production quotas by an average of 10% next year will help us continue that progress and make it harder to divert these drugs for abuse,” said Sessions, according to High Times.

    The DEA’s decision to raise the quota for research cannabis grown in the U.S. is a welcome change for researchers and advocates alike.

    Strict regulations surrounding the cultivation and dispensation of research cannabis has made it difficult for the body of research to catch up to the increasing number of states that are “legalizing it” in some form.

    The current White House is blamed for stalling progress on this issue. As of July 2018, STAT News reported that the DEA still had not granted additional licenses to cannabis growers, despite a 2016 announcement by the agency that it would be open up the application process to new growers.

    It was reported that the directive to stop accepting and processing new applications came from the Department of Justice via Attorney General Sessions.

    Sessions had hinted in April that, “fairly soon I believe… we will add additional suppliers of marijuana under controlled circumstances.” But despite this cryptic promise, and calls for change from bipartisan lawmakers in Congress, there’s been little movement on the issue.

    Perhaps the updated quotas may fill in the demand for research cannabis, though pain patients will no doubt worry about how lower opioid production will affect them.

    View the original article at thefix.com

  • Suboxone: A Tool for Recovery

    Suboxone: A Tool for Recovery

    With medication-assisted treatment (MAT), people with opioid addictions are given the chance to rebuild their lives—often from the ashes and debris of drug-induced destruction—without having to fight cravings and withdrawal.

    Suboxone is a prescription medication that treats opioid addiction. It contains buprenorphine and naloxone, active ingredients that are used to curb cravings and block the effects of opioids. Although a major player in addiction recovery today, and often referred to as the gold-standard of addiction care, many in the recovery community remain resistant and even wary, including a large portion of rehab facilities and many members of the 12-step community.

    How does Suboxone work? When an opioid like heroin hits your system, it causes a sense of euphoria, reduced levels of pain, and slowed breathing. The higher the dose, the more intense the effect. Buprenorphine and heroin are both considered opioids, but the way they bind with the opioid receptors in the brain differs. Heroin is a full agonist, meaning it activates the receptor completely and provides all of the desired effects. Buprenorphine is a long-acting partial agonist. While it still binds to the receptor, it is less activating than a full agonist, and there is a plateau level which means that additional doses will not create increased beneficial effects (although they may still cause increased adverse effects). In someone who has been addicted to opioids, buprenorphine will not cause feelings of euphoria—the sensation of being “high.” Naloxone is paired with the buprenorphine to discourage misuse; if Suboxone is injected, the presence of the naloxone may make the user extremely ill.

    Jail Physician and Addiction Specialist Dr. Jonathan Giftos, M.D. offers this analogy: “I describe opioid receptors as little ‘garages’ in the brain. Heroin (or any short-acting opioid) is like a car that parks in those garages. As the car pulls into the garage, the patient gets a positive opioid effect. As the car backs out of the garage, the patient experiences withdrawal symptoms. Buprenorphine works as a car that pulls into the same garage, providing a positive opioid effect—just enough to prevent withdrawal symptoms and reduce cravings, but unlike heroin, which backs out after a few hours causing withdrawal—buprenorphine pulls the parking brake and occupies garage for 24-36 hours. This causes the functional blockade of the opioid receptor, reducing illicit opioid use and risk of fatal overdose.”

    Critics and skeptics of medication-assisted treatment (MAT) believe that using Suboxone is essentially replacing one narcotic with another. While buprenorphine is technically considered a narcotic substance with addictive properties, there are important differences between using an opioid like heroin or oxycontin and physician-prescribed Suboxone. Similarities between using heroin and Suboxone are that you have to take the drug every day or you will experience withdrawal and likely become very ill. Aside from the physical dependency, which is without a doubt a burden, Suboxone offers people in recovery the opportunity to live a “normal” life, far removed from the drug culture lifestyle they may have been immersed in while using heroin.

    People are dying every day from heroin overdoses, especially now in the nightmarish age of fentanyl. People in recovery from opioid addiction are living, free from the risk of overdosing, on Suboxone. Suboxone is a harm reduction option that while initially raised some eyebrows is gaining more traction, and considered an obvious choice for treatment by addiction medicine professionals. While someone using heroin is tasked daily with coming up with money for their drugs, avoiding run-ins with police or authorities, meeting dealers and often participating in other criminal activity, someone using physician-prescribed Suboxone is not breaking the law. They are able to function normally and go to school or get a job, and they are often participating in other forms of ongoing treatment simultaneously. People are given the chance to rebuild their lives—often from the ashes and debris of drug-induced destruction—without having to fight cravings and withdrawal.

    There is a common misconception about Suboxone, and medication-assisted treatment in general, that it is a miracle medication that cures addiction. Because of this idea, many people use Suboxone and are disappointed when they relapse, quickly concluding that MAT doesn’t work for them. When visiting the website for the medication, it reads directly underneath “Important Safety Information” — “SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII) is a prescription medicine indicated for treatment of opioid dependence and should be used as part of a complete treatment plan to include counseling and psychosocial support.”

    So, as prescribed, Suboxone is intended to be only part of a treatment plan. It is but one tool in a toolbox with many other important tools such as counseling or therapy, 12-step meetings, building a support system, nurturing an aspect of your life that gives you purpose, and practicing self-care. It is medication-assisted treatment, emphasis on the assisted.

    With that being said, the type of additional treatment or self-care a person participates in should fit their own individual needs and comfort level and not be forced on them. Like a wise therapist once said, “Everybody has the right to self-determination.” Twelve-step meetings, although free and available to everyone, are not the ideal treatment for many people struggling with addiction. Therapy is expensive. People using Suboxone or other MAT shouldn’t be confined to predetermined treatment plans that have little to do with an individual’s needs and more to do with stigma-imposed restrictions.

    It’s unlikely that you’ll find a person claiming that simply taking Suboxone instead of heroin every day saved their life. It is not the mere replacement of one substance for another that is saving lives and treating even the most hopeless of people who have opioid use disorder; it is the relentless pursuit of a new way of life, a pursuit which includes rigorous introspection and a complete change of environment, peers, and daily life. Through the process of therapy, 12-step, using a recovery app, or whatever treatment suits you best, a person can face their demons, learn healthy coping mechanisms, and build confidence without the constant instability of cravings and withdrawal. Suboxone is giving people a chance that they just didn’t have before.

    So why is there such a stigma tied to the life-saving medication? Much of it comes from misinformation and is carried over from its predecessor—the stigma of addiction. It is hard for people who have a pre-existing disdain for addiction in general to swallow the idea that another “narcotic” medication may be the best form of treatment. In addition to addiction-naive civilians or “normies” as 12-steppers might call them, many members of the Narcotics Anonymous community are not completely sold on Suboxone’s curative potential either. Some members of the 12-step community are accepting of MAT, but you just don’t know what you’re going to get. You may walk into a meeting and have a group that is completely open and supportive of a decision to go through the steps while on Suboxone, or you may walk into a meeting of old-timers who are adamant that total abstinence is crucial to your success in the program.

    Another reason people are unconvinced is the length of time Suboxone users may or may not stay on the medication. Again, there is a stigma that shames people who use Suboxone long-term even though studies have shown long-term medication-assisted treatment is more successful than using it only as a detox aid. If Suboxone is helping a person live a productive life in a healthy environment, without the risk of overdose, that person should have the right to do so for however long they need without the scrutinizing gaze of others. While their critics are tsk-tsking away, they may be getting their law degree or buying their first home.

    Suboxone is a vastly misunderstood and complex medication that has the potential to not only save the lives of people with opioid addictions, but also allow them to recover and rebuild lives that were once believed to be beyond repair.

    View the original article at thefix.com

  • More ERs Are Providing Withdrawal Meds As First Step To Recovery

    More ERs Are Providing Withdrawal Meds As First Step To Recovery

    Patients in need are receiving buprenorphine to address their withdrawal symptoms. 

    Kicking an opioid habit comes with a host of physical withdrawal symptoms so severe that people often end up in the emergency room.

    There, they are usually treated for diarrhea or vomiting, but not the underlying issue. Now, however, more emergency rooms around the county are providing buprenorphine to help ease withdrawal and get more people into treatment. 

    “With a single ER visit we can provide 24 to 48 hours of withdrawal suppression, as well as suppression of cravings,” Dr. Andrew Herring, an emergency medicine specialist at Highland Hospital in Oakland, California, told The New York Times

    At Highland, people who come in presenting with withdrawal symptoms are given a dose of buprenorphine, also known as Suboxone, and are told to follow up with Herring, who runs the hospital’s buprenorphine program. 

    “It can be this revelatory moment for people—even in the depth of crisis, in the middle of the night,” Herring said. “It shows them there’s a pathway back to feeling normal.”

    Although the Drug Enforcement Administration (DEA) requires doctors to receive special training and a license to prescribe buprenorphine, doctors in the ER can provide the medication without this training. Still, Herring said, many healthcare providers hesitate to provide the first step toward medication-assisted treatment (MAT). 

    “At first it seemed so alien and far-fetched,” he said. 

    Yet, research into the practice is promising. A 2015 study showed that people who were given buprenorphine in the ER were twice as likely to be in treatment 30 days later than those who were not given medication to help with withdrawal.  

    “I think we’re at the stage now where emergency docs are saying, ‘I’ve got to do something,’” said Dr. Gail D’Onofrio, lead study author. “They’re beyond thinking they can just be a revolving door.”

    California has plans to expand treatment for withdrawal in emergency rooms, using $78 million in federal funding to establish a hub-and-spoke system where people would get their first dose of medication in the emergency room before being connected with ongoing services.

    Dr. Kelly Pfeifer, director of high-value care at the California Health Care Foundation, said this is the next step in providing quality care for people fighting addiction. 

    “We don’t think twice about someone having a heart attack, getting stabilized in the emergency department, and then getting ongoing care from the cardiologist,” she said. “And the risk of death within a year after an overdose is greater than it is for a heart attack.”

    View the original article at thefix.com

  • Are Construction Workers Hit Hardest By Opioid Addiction?

    Are Construction Workers Hit Hardest By Opioid Addiction?

    A new survey examined the occupations of those who died from opioid-related causes. 

    It’s been considered a problem for years, and a new study in Massachusetts has proven that the construction industry is the worst affected from opioid-related overdose deaths. Architecture and engineering are the only careers with higher death rates among women than men.

    “The primary workforce in construction is male, and they’re twice as common to abuse prescription drugs than females,” Eric Goplerud told Forbes. Goplerud is senior vice president of the Department of Substance Abuse Mental Health and Criminal Justice Studies at NORC at the University of Chicago.

    Dezeen magazine reported that the Massachusetts Department of Public Health published a report on the opioid epidemic in a state that had opioid overdose deaths more than double between 2011 and 2015. The Opioid-Related Overdose Deaths in Massachusetts by Industry and Occupation survey reviewed death certificates from those years to compile data about industry and occupation, gender, race, and age among the deaths.

    Between 2011 and 2015, 5,580 Massachusetts residents died from opioid-related overdoses. Some of these deaths were excluded from the study.

    Construction and extraction workers were found to make up over 24% of the total, the highest amount of any particular profession. The analysis of the study authors believe this is due to the high amount of injuries people in this field endure. The report quotes a statistic that four out of every 100 construction workers are injured on site.

    “Pain is a common feature among injured workers and previous research indicates that opioids are frequently prescribed for pain management following work-related injuries, which has the potential to lead to opioid use disorders,” according to Dezeen. The study was first reported by the Architect’s Newspaper.

    According to experts interviewed in the Forbes piece, changing the construction company owners’ approach to opioid abuse is not going to be easy. Many (if not most) construction companies have a zero tolerance policy regarding positive drug tests of workers. If a worker tests positive, it often means he or she loses the job.

    “You go on construction sites, and you see those signs saying ‘you’re out of there if you test positive,’” Boston Properties Life Safety and Security Assistant Director John Tello told Forbes. “It seems like there is a divide in what’s going on and what needs to be done to help these people.”

    “Helping wean workers off opioids as they prepare to return to work should be part of any rehabilitation treatment,” Goplerud told Forbes.

    View the original article at thefix.com

  • Could Informing Doctors Of Patients' Opioid Deaths Curb Prescribing?

    Could Informing Doctors Of Patients' Opioid Deaths Curb Prescribing?

    How are doctors’ prescribing behavior affected when they’re notified of their own patients’ opioid-related deaths?

    Some California doctors have recently received letters that changed how they prescribed opioids, according to new research.

    The letters informed doctors of the deaths of patients to whom they had prescribed opioids, according to the Washington Post. Such letters were part of a study conducted by researchers at the University of Southern California and published Thursday (August 9) in the journal Science.

    The letters were sent by the San Diego County Medical Examiner Office to hundreds of doctors who, in the past year, had prescribed opioids to a patient who later died.

    “This is a courtesy communication to inform you that your patient [name, date of birth] died on [date]. Prescription drug overdose was either the primary cause of death or contributed to the death,” the letters read. “We hope that you will take this as an opportunity to join us in preventing future deaths from drug overdose.”

    According to the Post, the idea behind the study was to close the gap between a doctor’s care and a doctor’s knowledge about the potential consequences of prescribing opioids.

    While many doctors are aware that opioid use disorder is a widespread issue, they may believe that the consequences affect other doctors’ patients rather than their own, the Post noted. 

    According to the results of the study, doctors who learned of a patient’s death at the hands of opioids were 7% less likely to prescribe opioids to new patients. Doctors who received a letter also had a tendency to prescribe fewer high-dose prescriptions within the next three months  of receiving the letter. The total amount of opioids these doctors prescribed decreased by 9.7%. 

    “What’s particularly interesting to me is the personal nature of it,” Alexander Chiu, a surgeon at Yale New Haven Hospital who was not involved in the study, told the Post. “Depending on what field you’re in, [the opioid epidemic] can feel a little remote. If you’re not a pain doctor or a primary-care doctor, it’s not quite as common to know or see your actions having a negative impact, which is what this is showing—it makes it very real. As evidence-based as we are as a profession, sometimes anecdotes can be really powerful.”

    Lead researcher Jason Doctor, director of health informatics at the University of Southern California’s Schaeffer Center for Health Policy and Economics, tells the Post that while doctors have knowledge of facts, they are still human.

    “One of the takeaways I’d like people to have is that doctors learn a lot of clinical facts, but when it comes to clinical judgment and decision-making, they fall prey to the same biases that we all do,” he said. 

    According to Doctor, San Diego County plans to continue sending these letters, and other counties have also said they are interested in doing something similar.

    View the original article at thefix.com

  • Fentanyl, Other Synthetic Drugs Drive National Overdose Rates Up

    Fentanyl, Other Synthetic Drugs Drive National Overdose Rates Up

    Nearly 30,000 Americans died from overdoses stemming from fentanyl and other synthetic opioids in 2017.

    Driven in large part by widespread opioid use, the number of drug overdoses nationwide shot up nearly 10% last year, according to preliminary federal figures. 

    The U.S. clocked more than 72,000 drug fatalities in 2017, the Centers for Disease Control and Prevention (CDC) reported last week. That’s up by more than 6,000 from the 2016 figures, bringing the tally to nearly 200 deaths a day—more than the total number of gun, car crash or HIV deaths in any single year, ever. 

    But the new numbers—which represent a two-fold increase over 10 years ago—could actually be underestimating the true scope of the problem as full data from some states still isn’t in yet. 

    A big chunk of the increase—nearly 50,000 fatalities—comes from opioid deaths, a category that’s more than quadrupled since 2002. An increase in cocaine fatalities is also feeding into the higher figures. 

    Meanwhile heroin, painkiller, and methadone fatality figures have started to flatten out; it’s fentanyl deaths that are continuing to rise. Last year, close to 30,000 Americans died from overdoses stemming from fentanyl and other synthetic opioids.

    “Seventy-five percent of the deaths we get are fentanyl-related,”  Al Della Fave, a spokesman for the Ocean County, New Jersey prosecutor, told the Washington Post. “It’s the heroin laced with synthetic opioids that we’re getting creamed with.”

    The biggest increases are in some of the East Coast states already hardest hit by opioids, including Ohio, West Virginia and New Jersey. 

    In part, that’s due to the geography of drug-trafficking patterns. On the East Coast, heroin typically comes in a stronger powdered form—a form more easily mixed with deadly fentanyl. But in the western part of the country, cartels bring in black tar heroin from Mexico, which is both weaker and harder to mix with fentanyl. 

    “It is the 2.0 of drugs right now, the synthetics,” Tom Synan, the police chief in Newtown, Ohio, told the Post

    The current influx in opioid fatalities is commonly traced back to the 1990s, when drugmakers pushed addictive painkillers and doctors overprescribed them.

    Over a decade later, heroin took hold again when a cheap supply reshaped the market. But in recent years, it’s the introduction of fentanyl and other powerful synthetics that has driven the crisis to a deadlier point.

    And now that there’s finally been a downturn in some types of opioid fatalities, experts predict that any downward trend could be gradual given the nature of addiction and the stigma surrounding it.

    “Because it’s a drug epidemic as opposed to an infectious disease epidemic like Zika, the response is slower,” University of California San Francisco professor Dan Ciccarone told the New York Times. “Because of the forces of stigma, the population is reluctant to seek care. I wouldn’t expect a rapid downturn; I would expect a slow, smooth downturn.”

    View the original article at thefix.com

  • Experts Develop Post-Surgery Opioid Guidelines To Curb Overprescribing

    Experts Develop Post-Surgery Opioid Guidelines To Curb Overprescribing

    “Our feeling is we shouldn’t just be using draconian, one-size-fits all prescribing,” said one expert from Johns Hopkins. 

    Surgeons at Johns Hopkins Hospital in Baltimore have developed opioid prescribing guidelines that are specific to 20 common surgeries, in an effort to reduce overprescribing. 

    “This work reflects that surgeons want to be a part of the solution,” Dr. Heidi Overton, a surgery resident at Johns Hopkins who worked on the guidelines, told The Baltimore Sun.

    The guidelines were published this week in the Journal of the American College of Surgeons. Previously, Johns Hopkins doctors generally prescribed a 30-day supply of opioid painkillers following surgery, a standard that was “dangerously high,” according to lead study author Dr. Martin Makary, a professor of surgery and health policy expert at the Johns Hopkins University School of Medicine. 

    The new guidelines take into account what type of surgery a patient had. The panel that made the recommendations suggested one to 15 opioid pills for 11 of the 20 procedures, 16 to 20 pills for six of the 20 procedures, and none for three of the procedures—a drastic reduction from previous prescribing practices. 

    Patients having orthopedic surgeries needed the most opioid painkillers and those having ear, nose and throat procedures needed the fewest, study authors said. Doctors can adjust their prescription based on specific patients’ needs as well. 

    “Our feeling is we shouldn’t just be using draconian, one-size-fits all prescribing,” said Makary. “Everyone is different. Opioid prescribing should fall within a best practices range and currently we don’t do very well with that. Our hope is that this represents a first step in better understanding how we can treat pain better.”

    Makary noted that one in 16 surgery patients become long-term drug users. He also explained that more than half of patients who did not need opioids to manage pain in the hospital are still sent home with a prescription. Because of that, 70 to 80% of opioids prescribed to patients are never used as prescribed.

    Changing standards around opioid prescriptions is part of addressing the current overdose crisis, he said.  

    “We don’t just need treatment and rehab facilities,” Makary said. “We shouldn’t just be cleaning up the floor, but we should be turning off the spigot of overprescribing that doctors did with good intention, but bad science.”

    Other teaching hospitals have tried to implement opioid prescription guidelines, but the American College of Surgeons has not addressed the issue.

    However, the organization is putting together a brochure “to help surgeons facilitate a dialog with their patients on postoperative pain relief.”

    View the original article at thefix.com